1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Quick-Med Technologies, Inc.

Quick-Med Technologies, Inc.

QMDT
Quick-Med Technologies, Inc.US flagOther OTC
0.00
USD
- -
- -
29,877.00Market Cap
Quick-Med Technologies, Inc.
QMDT
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
TTM
FRC
- -
- -
- -
0.01
0.04
0.06
0.04
0.03
0.03
0.03
0.03
- -
0.02
Revenue per Share
-0.07
-0.32
-0.14
-0.08
-0.06
-0.05
-0.08
-0.07
-0.11
-0.07
-0.05
- -
-0.02
Basic EPS, GAAP
-0.04
-0.09
-0.08
-0.06
-0.03
-0.02
-0.04
-0.03
-0.04
-0.04
-0.02
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.32
-0.62
-0.64
-0.54
-0.47
-0.52
-0.59
-0.65
-0.76
-0.79
-0.74
- -
-0.76
Book Value per Share
-0.14
-0.16
-0.15
-0.03
-0.05
-0.08
-0.13
-0.17
-0.21
-0.21
-0.23
- -
-0.25
Tangible Book Value per Share
12
13
16
23
30
30
31
31
31
33
37
- -
37
Basic Weighted Avg Shares
- -
- -
- -
- -
1
2
1
1
1
1
1
1
1
Sales/Revenue/Turnover
- -
- -
-4,740.57
-1,020.05
-133.02
-80.76
-163.47
-175.67
-209.77
-197.37
-124.14
-40.5
-40.5
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
-4
-2
-2
-2
-2
-2
-2
-4
-2
-2
-1
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-4,934.4
-1,060.59
-138.25
-77.12
-175.61
-201.31
-357.18
-221.55
-169.11
-76.8
-76.8
Profit Margin (%)
-2
-2
-1
1
- -
- -
-1
-1
- -
- -
-8
-8
-8
Working Capital
- -
- -
- -
1
1
2
3
4
7
- -
- -
- -
- -
LT Debt
-1
-2
-2
- -
-1
-2
-4
-5
-6
-6
-8
-9
-9
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-3.06
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'13
Mar'13
Jun'13
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
2
3
2

Working Capital

FRC

•

in mil. unless spec.
Dec'13
Mar'13
Jun'13
Total Current Assets
1
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
9
9
9
Payables & Accruals
8
8
8
ST Debt
- -
- -
- -
Deferred Revenue
1
1
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
44.38%
20.92%
12.33%
Free Cash Flow
-5.47%
-22.38%
-99.91%
Net Income, GAAP
-8.7%
-11.89%
-57.73%
Sales/Revenue/Turnover
- -
-6.72%
-6.92%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
- -
- -
- -
- -
1
2012
- -
- -
- -
- -
1
2013
- -
- -
- -
- -
1

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
-0.01
-0.01
-0.02
- -
-0.07
2012
-0.01
-0.01
-0.01
- -
-0.05
2013
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -
Similar Companies
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (300026.SZ)
Upper Street Marketing Inc. (UPPR)
Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)
Qol Holdings Co., Ltd. (3034.T)
Rimrock Gold Corp. (RMRK)
Islet Holdings, Inc. (ISHI)
Business
Quick-Med Technologies, Inc. is a US-based life sciences company specializing in the development, manufacturing, and commercialization of proprietary antimicrobial chemical technologies. The company's core products include two patented antimicrobial platforms: NIMBUS and Stay-Fresh. NIMBUS is a non-leaching, long-chain cationic quaternary polymer used primarily in medical wound dressings such as the BIOGUARD dressing line, which offers durable, broad-spectrum antimicrobial protection against resistant bacteria including MRSA and VRE. Stay-Fresh technology incorporates hydrogen peroxide sequestered in a zinc oxide binder, providing sustainable and highly durable antimicrobial effects for medical and consumer textiles, surface coatings, and other non-medical applications. These products emphasize safety, efficacy, sustainability, and cost-effectiveness. Quick-Med Technologies operates globally, serving markets in both medical and non-medical sectors with applications ranging from wound care to antimicrobial textiles and coatings. The company focuses on reducing bacterial resistance risks while advancing environmental sustainability through green chemical formulations. Its technologies have FDA clearance and are recognized for biocompatibility and long-lasting antimicrobial performance. In the last 1-2 years, Quick-Med Technologies has expanded its Stay-Fresh product applications, continuously developing new offerings for medical textiles and other surfaces, reinforcing its commitment to sustainable antimicrobial solutions. The company highlights ongoing partnerships, such as the joint development of BIOGUARD dressings with Derma Sciences using NIMBUS technology. Quick-Med maintains active regulatory support and production scale-up for these innovations to meet growing market demand. Founded in 1992, Quick-Med Technologies is headquartered in the United States and actively pursues innovation in antimicrobial stewardship, leveraging its patented green chemistry technologies to serve healthcare providers, manufacturers of medical and consumer products, and global end-users seeking advanced antimicrobial protection. Its business emphasizes proprietary technology development, product commercialization, and global distribution channels within the life sciences and chemical technology sectors. This comprehensive product portfolio and recent strategic expansion of antimicrobial textile and coating applications underscore Quick-Med Technologies' role as a key player in sustainable antimicrobial innovation worldwide.